University Hospital Campus BioMedico
Rome, Italy
NCT Number: NCT01763801
Intravenous electrocardiographic guidance (IVECG) is a safe, reliable and accurate technique to correctly position the catheter tip. The investigators sought to evaluate the superiority of the P-maximal (P-max) wave compared to the P-submaximal (P-submax) wave in obtaining a more correct, safer and longer lasting device placement, with a lower incidence of complications and secondary misplacement.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Phase 4
Rome, Italy
This prospective randomized trial was designed to observe the placement of long term iv catheters obtained with the IVECG method. Patients were randomised into 2 groups: in group A the catheter tip was placed in correspondence to the P-max, in group B in correspondence to the P-submax. We followed up the tip position by measuring the variation of its distances from the tracheal carina on multiplanar reconstructions of volumetric CT scans taken within a month (T0) and a year (T1) from the port implant.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
tip placement in correspondence to the P-Max on the ECG
tip placement in correspondence to the P-Submax on the ECG
Time frame: up to 10 months
Campus Bio-Medico University
Other
P-max or P-submax? This is the Question! A Prospective Randomized Search of the Most Reliable ECG Landmark for a Long Term Central Venous Catheter.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05911451
Arteriovenous Fistula, Arteriovenous Graft
Alkmaar, Netherlands
View Trial DetailsNCT05741866
Cardiovascular Diseases, Catheter Complications
Herston, Queensland, Australia
View Trial DetailsNCT02513303
Arteriovenous Fistula, Arteriovenous Malformations
Huntsville, Alabama, United States
View Trial DetailsNCT05425056
Arteriovenous Fistula, Arteriovenous Malformations
San Diego, California, United States
View Trial Details